February 2015
UA Local 190 health and welfare plan added to Medical Drug Prior Authorization Program
Effective April 1, 2015, all groups enrolled in the UA Local 190 health and welfare plan will participate in the Medical Drug Prior Authorization Program.
Note: The prior authorization requirement does not apply to Medicare, Medicare Advantage or Federal Employee Program® members.
The list below reflects all the medications that are part of the Medical Drug Prior Authorization Program.
Actemra® |
Flebogamma® DIF |
Nplate® |
Acthar® gel |
Gammagard Liquid |
Octagam® |
Adagen® |
Gammagard® S/D |
Orencia® |
Aldurazyme® |
Gammaked® |
Privigen® |
Aralast NP |
Gammaplex® |
Prolastin®-C |
Benlysta® |
Gamunex® |
Prolia® |
Berinert® |
Glassia |
Ruconest® |
Bivigam™ |
Hizentra® |
Simponi® Aria™ |
Botox® |
HyQvia |
Soliris® |
Carimune® NF |
Ig, IV injection NOS |
Stelara® |
Cerezyme® |
Ilaris® |
Synagis® |
Cimzia® |
Kalbitor® |
Tysabri® |
Cinryze® |
Krystexxa® |
Vimizim™ |
Dysport® |
Lemtrada™ |
Vpriv® |
Elaprase® |
Lumizyme® |
Xeomin® |
Elelyso™ |
Makena® |
Xgeva® |
Entyvio™ |
Myobloc® |
Xiaflex® |
Fabrazyme® |
Myozyme® |
Xolair® |
Firazyr® |
Naglazyme® |
Zemaira® |
For more information about this change, contact your provider consultant. |